Press Releases Our top headlines making news around the world BlogPress Releases Tel Aviv Sourasky Medical Center Chooses SOPHiA DDM™ HRD Solution of SOPHiA GENETICS READ MORE Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test READ MORE SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis READ MORE SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results READ MORE University of Arkansas for Medical Sciences Will Use SOPHiA GENETICS to Advance Clinical Research for Blood Cancers READ MORE SOPHiA GENETICS Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023 READ MORE SOPHiA GENETICS and QIAGEN forge partnership to combine strengths in next-generation sequencing READ MORE Synergy Laboratories Taps SOPHiA GENETICS Technology for New Cancer Profiling Solution READ MORE SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023 READ MORE SOPHiA GENETICS Expands Partnership with AstraZeneca to include Multimodal Approaches for Cancer Drug Development READ MORE SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies READ MORE New Data Presented at ESGO Showcases Clinical Relevance of SOPHiA DDM™ Dx HRD Solution READ MORE « Older Entries Next Entries » Want to know more? Get in touch with us. Our client services team is on hand to help. First Name(Required) Last Name(Required) Institution(Required) Job Title/Industry(Required)RoleArtificial Intelligence/Machine LearningBiomarkers and DiagnosticsBusiness, Strategy, and InnovationClinical OperationsData ScienceDepartment HeadExecutive/Corporate ManagementGenetics CounselorHospital ManagementLab Manager/DirectorMedical AffairsPartner/DistributorPathologistPharmaceutical/CROPhysician/ClinicianR&DRWD/RWEScientist/ResearcherStudentOtherArea of Interest(Required)Area of InterestsAdministrativeAlamut Visual PlusBioPharma CollaborationBlood CancersData AccessData AnalyticsHereditary CancersLIMS/EHR integrationLiquid BiopsyMultimodal applicationsRare and Inherited DiseaseSmart DiagnosticsSolid TumorsSophia DDM PlatformOtherEmail(Required) Phone(Required)Country(Required)Select CountryAfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustralia*AustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius, and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazil*British Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanada*Cape VerdeCayman IslandsCentral African RepublicChadChileChina*Christmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, the Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard and McDonald IslandsHoly See (Vatican City State)HondurasHungaryIcelandIndia*IndonesiaIran, Islamic Republic ofIraqIreland*Isle of ManIsraelItaly*JamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People’s Republic ofKorea, Republic ofKosovoKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMartiniqueMauritaniaMauritiusMayotteMexico*Moldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MaceedoniaNorwayOmanPakistanPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalQatarRomaniaRussian FederationRwandaSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan Mayen IslandsSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTürkiyeTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States*UruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofVietnamVirgin Islands, BritishWallis and FutunaWestern SaharaYemenZambiaZimbabweSelect US StateSelect StateALAKAZARCACOCTDEDCFLGAHIIDILINIAKAKYLAMEMDMAMIMNMSMOMTNENVNHNJNMNYNCNDOHOKORPARISCSDTNTXUTVTVAWAWVWIWYCity Select ProvinceSelect ProvinceAlberta, CABritish Columbia, CAManitoba, CANew Brunswick, CANewfoundland and Labrador, CANorthwest Territories, CANova Scotia, CANunavut, CAOntario, CAPrince Edward Island, CAQuebec, CASaskatchewan, CAYukon, CAContact Reason(Required)Contact ReasonInformation on our solutionsRequest a demoMediaCareersSpeak to SalesType Your Message(Required)Privacy Policy(Required) By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy Marketing Opt-In I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time. CAPTCHAPhoneThis field is for validation purposes and should be left unchanged.
Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test READ MORE
University of Arkansas for Medical Sciences Will Use SOPHiA GENETICS to Advance Clinical Research for Blood Cancers READ MORE
SOPHiA GENETICS Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023 READ MORE
SOPHiA GENETICS and QIAGEN forge partnership to combine strengths in next-generation sequencing READ MORE
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023 READ MORE
SOPHiA GENETICS Expands Partnership with AstraZeneca to include Multimodal Approaches for Cancer Drug Development READ MORE
SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies READ MORE